Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma

Mumtaz V Rojiani, Janeen Alidina, Nicole Esposito, Amyn Mohammed Rojiani

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMP) have been implicated in increased invasive and metastatic potential of tumors, possibly via interactions with the extracellular matrix and angiogenesis. This study investigates the relationship between MMP-2 immunoexpression and angiogenesis in a series of lung carcinomas metastatic to the central nervous system (CNS). Twenty eight metastatic carcinoma cases with adequate brain-tumor interface were identified from the archives at the Moffitt Cancer Center. MMP-2 expression was determined by immunohistochemistry using an antibody directed against pro and active forms (NeoMarkers). Similarly, microvessels were identified on parallel sections with anti-CD34 antibody (Biogenix). Angiogenesis profiles within the tumor and at the CNS/tumor interface were morphometrically assessed by the Image Pro Plus image analysis system. Briefly, CD34 positive vessels were quantitated and correlated with presence or absence of MMP-2 expression in the tumor. Mean microvessel area (MMVA) and mean microvessel number (MMVN) were assessed within areas of brain-tumor interface and within the tumor and expressed as a ratio relative to the tumor. Sixteen (57.14%) metastatic tumors were strongly immunoreactive for MMP-2, while 12 (42.86%) were negative. MMP-2 positive tumors had a higher MMVA and MMVN ratio at the CNS/tumor interface in comparison to MMP-2 negative neoplasms. MMP-2 expression thus appears to confer enhanced vascular proliferation particularly at the brain-tumor interface which would support the contention of enhanced capability of growth and invasion within the CNS, possibly modulated by MMP2. The relationship between MMP-2 expression and angiogenesis has been previously reported and its biological and therapeutic implications remain the focus of investigations.

Original languageEnglish (US)
Pages (from-to)775-781
Number of pages7
JournalInternational Journal of Clinical and Experimental Pathology
Volume3
Issue number8
StatePublished - Dec 1 2010

Fingerprint

Matrix Metalloproteinase 2
Central Nervous System
Neoplasm Metastasis
Carcinoma
Lung
Microvessels
Neoplasms
Brain Neoplasms
Central Nervous System Neoplasms
Matrix Metalloproteinases
Extracellular Matrix
Blood Vessels
Anti-Idiotypic Antibodies
Immunohistochemistry
Antibodies
Growth

Keywords

  • Angiogenesis
  • CNS metastasis
  • Lung cancer
  • Matrix metalloproteinases (MMP)

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma. / Rojiani, Mumtaz V; Alidina, Janeen; Esposito, Nicole; Rojiani, Amyn Mohammed.

In: International Journal of Clinical and Experimental Pathology, Vol. 3, No. 8, 01.12.2010, p. 775-781.

Research output: Contribution to journalArticle

@article{515da370785d4df39b4fc265c2e33378,
title = "Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma",
abstract = "Matrix metalloproteinases (MMP) have been implicated in increased invasive and metastatic potential of tumors, possibly via interactions with the extracellular matrix and angiogenesis. This study investigates the relationship between MMP-2 immunoexpression and angiogenesis in a series of lung carcinomas metastatic to the central nervous system (CNS). Twenty eight metastatic carcinoma cases with adequate brain-tumor interface were identified from the archives at the Moffitt Cancer Center. MMP-2 expression was determined by immunohistochemistry using an antibody directed against pro and active forms (NeoMarkers). Similarly, microvessels were identified on parallel sections with anti-CD34 antibody (Biogenix). Angiogenesis profiles within the tumor and at the CNS/tumor interface were morphometrically assessed by the Image Pro Plus image analysis system. Briefly, CD34 positive vessels were quantitated and correlated with presence or absence of MMP-2 expression in the tumor. Mean microvessel area (MMVA) and mean microvessel number (MMVN) were assessed within areas of brain-tumor interface and within the tumor and expressed as a ratio relative to the tumor. Sixteen (57.14{\%}) metastatic tumors were strongly immunoreactive for MMP-2, while 12 (42.86{\%}) were negative. MMP-2 positive tumors had a higher MMVA and MMVN ratio at the CNS/tumor interface in comparison to MMP-2 negative neoplasms. MMP-2 expression thus appears to confer enhanced vascular proliferation particularly at the brain-tumor interface which would support the contention of enhanced capability of growth and invasion within the CNS, possibly modulated by MMP2. The relationship between MMP-2 expression and angiogenesis has been previously reported and its biological and therapeutic implications remain the focus of investigations.",
keywords = "Angiogenesis, CNS metastasis, Lung cancer, Matrix metalloproteinases (MMP)",
author = "Rojiani, {Mumtaz V} and Janeen Alidina and Nicole Esposito and Rojiani, {Amyn Mohammed}",
year = "2010",
month = "12",
day = "1",
language = "English (US)",
volume = "3",
pages = "775--781",
journal = "International Journal of Clinical and Experimental Pathology",
issn = "1936-2625",
publisher = "e-Century Publishing Corporation",
number = "8",

}

TY - JOUR

T1 - Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma

AU - Rojiani, Mumtaz V

AU - Alidina, Janeen

AU - Esposito, Nicole

AU - Rojiani, Amyn Mohammed

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Matrix metalloproteinases (MMP) have been implicated in increased invasive and metastatic potential of tumors, possibly via interactions with the extracellular matrix and angiogenesis. This study investigates the relationship between MMP-2 immunoexpression and angiogenesis in a series of lung carcinomas metastatic to the central nervous system (CNS). Twenty eight metastatic carcinoma cases with adequate brain-tumor interface were identified from the archives at the Moffitt Cancer Center. MMP-2 expression was determined by immunohistochemistry using an antibody directed against pro and active forms (NeoMarkers). Similarly, microvessels were identified on parallel sections with anti-CD34 antibody (Biogenix). Angiogenesis profiles within the tumor and at the CNS/tumor interface were morphometrically assessed by the Image Pro Plus image analysis system. Briefly, CD34 positive vessels were quantitated and correlated with presence or absence of MMP-2 expression in the tumor. Mean microvessel area (MMVA) and mean microvessel number (MMVN) were assessed within areas of brain-tumor interface and within the tumor and expressed as a ratio relative to the tumor. Sixteen (57.14%) metastatic tumors were strongly immunoreactive for MMP-2, while 12 (42.86%) were negative. MMP-2 positive tumors had a higher MMVA and MMVN ratio at the CNS/tumor interface in comparison to MMP-2 negative neoplasms. MMP-2 expression thus appears to confer enhanced vascular proliferation particularly at the brain-tumor interface which would support the contention of enhanced capability of growth and invasion within the CNS, possibly modulated by MMP2. The relationship between MMP-2 expression and angiogenesis has been previously reported and its biological and therapeutic implications remain the focus of investigations.

AB - Matrix metalloproteinases (MMP) have been implicated in increased invasive and metastatic potential of tumors, possibly via interactions with the extracellular matrix and angiogenesis. This study investigates the relationship between MMP-2 immunoexpression and angiogenesis in a series of lung carcinomas metastatic to the central nervous system (CNS). Twenty eight metastatic carcinoma cases with adequate brain-tumor interface were identified from the archives at the Moffitt Cancer Center. MMP-2 expression was determined by immunohistochemistry using an antibody directed against pro and active forms (NeoMarkers). Similarly, microvessels were identified on parallel sections with anti-CD34 antibody (Biogenix). Angiogenesis profiles within the tumor and at the CNS/tumor interface were morphometrically assessed by the Image Pro Plus image analysis system. Briefly, CD34 positive vessels were quantitated and correlated with presence or absence of MMP-2 expression in the tumor. Mean microvessel area (MMVA) and mean microvessel number (MMVN) were assessed within areas of brain-tumor interface and within the tumor and expressed as a ratio relative to the tumor. Sixteen (57.14%) metastatic tumors were strongly immunoreactive for MMP-2, while 12 (42.86%) were negative. MMP-2 positive tumors had a higher MMVA and MMVN ratio at the CNS/tumor interface in comparison to MMP-2 negative neoplasms. MMP-2 expression thus appears to confer enhanced vascular proliferation particularly at the brain-tumor interface which would support the contention of enhanced capability of growth and invasion within the CNS, possibly modulated by MMP2. The relationship between MMP-2 expression and angiogenesis has been previously reported and its biological and therapeutic implications remain the focus of investigations.

KW - Angiogenesis

KW - CNS metastasis

KW - Lung cancer

KW - Matrix metalloproteinases (MMP)

UR - http://www.scopus.com/inward/record.url?scp=79953159471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953159471&partnerID=8YFLogxK

M3 - Article

C2 - 21151391

AN - SCOPUS:79953159471

VL - 3

SP - 775

EP - 781

JO - International Journal of Clinical and Experimental Pathology

JF - International Journal of Clinical and Experimental Pathology

SN - 1936-2625

IS - 8

ER -